Loading clinical trials...
Loading clinical trials...
This is an investigator-initiated, two-year, randomized, controlled, single-center, open-label, pilot study comparing 3-drug highly active antiretroviral therapy (HAART) to 3-drug HAART plus raltegrav...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Washington
Collaborators
NCT07209917 · Cervical Cancer, Human Papillomavirus (HPV) Infection, and more
NCT07044297 · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
NCT07466836 · Human Immunodeficiency Virus (HIV)
NCT07143968 · MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, HIV (Human Immunodeficiency Virus)
NCT04958122 · Syphilis, Human Immunodeficiency Virus
University of Washington Primary Infection Clinic
Seattle, Washington
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions